SCHEMBL20747608

SCHEMBL20747608

CCCCCCC(C)(CC)COC(=O)C(C)N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
HSD17B10 Q99714 1/20 0.41
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
NFKB1 P19838 1/20 0.38
ADRA1A P35348 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20747628 0.91 LMNA (0.49) LMNAHSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL20747641 0.87 LMNA (0.46) LMNAHSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL20747637 0.84 GRIN2D (0.41) LMNAHSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL20747677 0.83 GRIN2D (0.47) LMNAHSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL20747678 0.82 GRIN2D (0.42) LMNAHSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL24943436 0.81 NAAA (0.40) TSHRRAB9AMAPTMEN1KMT2A
SCHEMBL20747738 0.79 LMNA (0.42) LMNAHSD17B10TSHRCYP3A4NFKB1
SCHEMBL20747647 0.77 MAPT (0.37) LMNAHSD17B10TSHRCYP3A4NFKB1
SCHEMBL20747640 0.77 GRIN2D (0.43) LMNAHSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL18857424 0.75 TSHR (0.50) LMNAHSD17B10TSHRCYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208045-B2 Aza-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208045-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK LMNA 2972/4885HSD17B10 3567/4885GRIN2D 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.